Pharmacokinetics of Pindolol in Man

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1974 Jan 1

PMID 4853602

Citations 35

Authors

R Gugler

W Herold

H J DENGLER

Affiliations

Soon will be listed here.

Citing Articles

Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Bouchard J, Shepherd G, Hoffman R, Gosselin S, Roberts D, Li Y Crit Care. 2021; 25(1):201.

PMID: 34112223 PMC: 8194226. DOI: 10.1186/s13054-021-03585-7.

Octopamine signaling in the metazoan pathogen : localization, small-molecule screening and opportunities for drug development.

El-Sakkary N, Chen S, Arkin M, Caffrey C, Ribeiro P Dis Model Mech. 2018; 11(7).

PMID: 29925529 PMC: 6078403. DOI: 10.1242/dmm.033563.

Multi-functional scaling methodology for translational pharmacokinetic and pharmacodynamic applications using integrated microphysiological systems (MPS).

Maass C, Stokes C, Griffith L, Cirit M Integr Biol (Camb). 2017; 9(4):290-302.

PMID: 28267162 PMC: 5729907. DOI: 10.1039/c6ib00243a.

Presynaptic selectivity of a ligand for serotonin 1A receptors revealed by in vivo PET assays of rat brain.

Saijo T, Maeda J, Okauchi T, Maeda J, Morio Y, Kuwahara Y PLoS One. 2012; 7(8):e42589.

PMID: 22880045 PMC: 3413639. DOI: 10.1371/journal.pone.0042589.

Bioavailability of beta-adrenoceptor blocking drugs.

Johnsson G, Regardh C Br J Clin Pharmacol. 2012; 3(6):1064-5.

PMID: 22216533 PMC: 1428968. DOI: 10.1111/j.1365-2125.1976.tb00361.x.

References

PACHA W . A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine. Experientia. 1969; 25(8):802-3. DOI: 10.1007/BF01897885. View

Martin B . Drug urinary excretion data--some aspects concerning the interpretation. Br J Pharmacol Chemother. 1967; 29(2):181-93. PMC: 1557205. DOI: 10.1111/j.1476-5381.1967.tb01951.x. View

Lubawski I, Wale J . Studies with LB 46, a new beta-receptor blocking drug. Eur J Pharmacol. 1969; 6(3):345-8. DOI: 10.1016/0014-2999(69)90195-2. View

SHAND D, Nuckolls E, OATES J . Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther. 1970; 11(1):112-20. DOI: 10.1002/cpt1970111112. View

Hill R, Turner P . Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man. Br J Pharmacol. 1969; 36(2):368-72. PMC: 1703386. DOI: 10.1111/j.1476-5381.1969.tb09511.x. View

Nuesch E . Proof of the general validity of Dost's law of corresponding areas. Eur J Clin Pharmacol. 1973; 6(1):33-43. DOI: 10.1007/BF00561799. View

Fitzgerald J, SCALES B . Effect of a new adrenergic beta-blocking agent (ICI 50,172) on heart rate in relation to its blood levels. Int Z Klin Pharmakol Ther Toxikol. 1968; 1(6):467-74. View

George C, Fenyvesi T, Conolly M, Dollery C . Pharmacokinetics of dextro-, laevo- and racemic propranolol in man. Eur J Clin Pharmacol. 1972; 4(2):74-6. DOI: 10.1007/BF00562500. View

Levy J . Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist. J Clin Pharmacol New Drugs. 1971; 11(4):249-60. View

10.

Krieglstein J, KUSCHINSKY G . [Quantitative determination of protein binding of drugs by gel filtration]. Arzneimittelforschung. 1968; 18(3):287-9. View

11.

Giudicelli J, Schmitt H, BOISSIER J . Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug. J Pharmacol Exp Ther. 1969; 168(1):116-26. View

12.

BODEM G, Chidsey C . Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man. Clin Pharmacol Ther. 1973; 14(1):26-9. DOI: 10.1002/cpt197314126. View

13.

Hill R, Turner P . The effects of a new beta-adrenoceptive receptor blocking drug on heart rate in man. Br J Pharmacol Chemother. 1968; 32(3):663-70. PMC: 1570309. DOI: 10.1111/j.1476-5381.1968.tb00465.x. View

14.

Koch-Weser J . Drug therapy. Serum drug concentrations as therapeutic guides. N Engl J Med. 1972; 287(5):227-31. DOI: 10.1056/NEJM197208032870505. View

15.

Barrett A, Carter J . Comparative chronotropic activity of beta-adrenoceptive antagonists. Br J Pharmacol. 1970; 40(3):373-81. PMC: 1703170. DOI: 10.1111/j.1476-5381.1970.tb10619.x. View

16.

Hicks D, Arbab A, Turner P, Hills M . A comparison of intravenous pindolol and propranolol in normal man. J Clin Pharmacol New Drugs. 1972; 12(5):212-6. DOI: 10.1002/j.1552-4604.1972.tb00164.x. View

17.

DENGLER H, BODEM G, Wirth K . [Pharmacokinetic studies on H3-digoxin and H3-lanatosid in man]. Arzneimittelforschung. 1973; 23(1):64-74. View

18.

SAAMELI K . [Comparative studies with beta-receptor blocking agents and quinidine]. Helv Physiol Pharmacol Acta. 1967; 25(4):CR432+. View